The series of disease-preventing vaccines have diphtheria, tetanus, whooping cough and poliomyelitis, as well as Haemophilus influenzae type B infections, and cannot be marketed and used. The reason for the suspension in trading is the suspicion that the quality requirements are not met.
The decision was made immediately enforceable. For series: Pentaxim, powder and suspension for suspension for injection, 1 vial. powder + 1 amp. syringe with 0,5 ml suspension with 2 separate needles. Lot number: K 4120-1, expiry date 04.2015.
The responsible entity is Sanofi Pasteur SA France.
Author: Katarzyna Wróblewska
Source: gif.gov.pl